The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human dose-escalating trial of E.coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors.
 
Thomas Kenwise Chung
No Relationships to Disclose
 
Eben Rosenthal
Honoraria - Novadaq Technologies
Research Funding - Genentech (Inst); LI-COR Biosciences (Inst); Novadaq Technologies (Inst)
 
William B Parker
Leadership - PNP Therapeutics
Stock and Other Ownership Interests - PNP Therapeutics
Research Funding - PNP Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Southern Research Institute (Inst)
 
Paula Allan
Stock and Other Ownership Interests - PNP Therapeutics
Research Funding - PNP Therapeutics (Inst)
 
Lisa Clemons
Research Funding - PNP Therapeutics (Inst)
 
Deborah Lowman
Research Funding - PNP Therapeutics (Inst)
 
Jeong Hong
Patents, Royalties, Other Intellectual Property - PNP Therapeutics
 
Frank R Hunt
Employment - PNP Therapeutics
Leadership - PNP Therapeutics
Stock and Other Ownership Interests - PNP Therapeutics
Travel, Accommodations, Expenses - PNP Therapeutics
 
Joshua Richman
No Relationships to Disclose
 
Robert Martin Conry
No Relationships to Disclose
 
Kyle Mannion
No Relationships to Disclose
 
William Carroll
No Relationships to Disclose
 
Lisle Nabell
No Relationships to Disclose
 
Eric J Sorscher
Leadership - PNP Therapeutics
Stock and Other Ownership Interests - PNP Therapeutics
Honoraria - Ambry Genetics
Consulting or Advisory Role - PNP Therapeutics
Patents, Royalties, Other Intellectual Property - PNP Therapeutics